Communiqués Yabao Pharmaceutical Group Co., Ltd

Actions

Cours en clôture Shanghai S.E. Autres places de cotation 24/07/2026			Varia. 5j.	Varia. 1 janv.
6,410 ^CNY	-2,73%		-5,74%	-1,23%

25/05	Une filiale de Yabao Pharmaceutical obtient le feu vert réglementaire chinois pour des comprimés contre le cholestérol	MT
24/04	Yabao Pharmaceutical Group Co., Ltd publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

30/06/16	Yabao Pharmaceutical : Pharmaceuticals and LFB Biomedicaments Enter Into Strategic Partnership to Deliver VIALEBEX® (LFB’s Human Albumin) in China	BU
20/04/16	Yabao Pharmaceutical : Pharmaceuticals and Salus Pharma Announce Strategic Partnership for Generic Drugs	BU
12/01/16	Yabao Pharmaceuticals : and Sciecure Pharma Announce Strategic Partnership to Co-develop, Manufacture and Commercialize Generics for U.S. and China	BU
20/10/15	Yabao Pharmaceuticals : Enters Second Innovative Collaboration With Eli Lilly and Company to Develop Diabetes Treatment	BU
15/09/15	Yabao Pharmaceuticals : and Primary Peptides Announce Exclusive China Partnership	BU
07/09/15	Yabao Pharmaceuticals : and University of South Australia Announce New Joint Drug Discovery Laboratory	BU